Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-05

Clinical Trial Update: Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of a risedronate and cholecalciferol combination tablet in osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risedronate and cholecalciferol combination tablet

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2019-08-05